                         SEQUENCE LISTING

<110>  INTARCIA THERAPEUTICS, INC.
 
<120>  USE OF HUMAN AMYLIN ANALOG POLYPEPTIDES FOR PROVIDING SUPERIOR 
       GLYCEMIC CONTROL TO TYPE 1 DIABETICS

<130>  717156: 102487-060WO

<140>
<141>

<150>  63/012,619
<151>  2020-04-20

<160>  5     

<170>  PatentIn version 3.5

<210>  1
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"


<220>
<221>  DISULFIDE
<222>  (2)..(7)
<223>  DISULFIDE

<220>
<221>  MOD_RES
<222>  (16)..(16)
<223>  D-Lys(gammaGlu-gammaGlu-CO(CH2)14CH3)

<400>  1

Ser Cys Asn Thr Ser Thr Cys Ala Thr Gln Arg Leu Ala Asn Glu Xaa 
1               5                   10                  15      


His Lys Ser Ser Asn Asn Phe Gly Pro Ile Leu Pro Pro Thr Lys Val 
            20                  25                  30          


Gly Ser Glu Thr Tyr 
        35          


<210>  2
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Lys(gammaGlu-gammaGlu-CO(CH2)18CO2H)

<220>
<221>  DISULFIDE
<222>  (2)..(7)
<223>  DISULFIDE

<400>  2

Lys Cys Asn Thr Ser Thr Cys Ala Thr Gln Arg Leu Ala Asn Glu Leu 
1               5                   10                  15      


His Lys Ser Ser Asn Asn Phe Gly Pro Ile Leu Pro Pro Thr Lys Val 
            20                  25                  30          


Gly Ser Glu Thr Tyr 
        35          


<210>  3
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Lys(gammaGlu-gammaGlu-CO(CH2)16CO2H)

<220>
<221>  DISULFIDE
<222>  (2)..(7)
<223>  DISULFIDE

<400>  3

Lys Cys Asn Thr Ser Thr Cys Ala Thr Gln Arg Leu Ala Asn Glu Leu 
1               5                   10                  15      


His Lys Ser Ser Asn Asn Phe Gly Pro Ile Leu Pro Pro Thr Lys Val 
            20                  25                  30          


Gly Ser Glu Thr Tyr 
        35          


<210>  4
<211>  37
<212>  PRT
<213>  Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Lys(gammaGlu-CO(CH2)16CO2H)

<220>
<221>  DISULFIDE
<222>  (2)..(7)
<223>  DISULFIDE

<400>  4

Lys Cys Asn Thr Ser Thr Cys Ala Thr Ser Arg Leu Ala Asn Phe Leu 
1               5                   10                  15      


Gln Lys Ser Ser Asn Asn Phe Gly Pro Ile Leu Pro Pro Thr Lys Val 
            20                  25                  30          


Gly Ser Glu Thr Tyr 
        35          


<210>  5
<211>  37
<212>  PRT
<213>  Homo sapiens


<220>
<221>  DISULFIDE
<222>  (2)..(7)
<223>  DISULFIDE

<400>  5

Lys Cys Asn Thr Ala Thr Cys Ala Thr Gln Arg Leu Ala Asn Phe Leu 
1               5                   10                  15      


Val His Ser Ser Asn Asn Phe Gly Ala Ile Leu Ser Ser Thr Asn Val 
            20                  25                  30          


Gly Ser Asn Thr Tyr 
        35          


